Nurix Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.651; its P/E ratio is -5.45; Nurix Therapeutics is scheduled to report earnings on July 10, 2024, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.

	Feb 24	Nov 23	Aug 23	May 23	Feb 23
Income Statement	-
Total Revenue	$ 16.59M	$ 15.16M	$ 18.47M	$ 30.68M	$ 12.69M
Gross Profit	$ 16.59M	$ 15.16M	$ 18.47M	$ 30.68M	$ 12.69M
EBIT	$ -41.43M	$ -41.96M	$ -36.98M	$ -24.28M	$ -40.73M
EBITDA	$ -39.47M	$ -40.20M	$ -35.24M	$ -21.93M	$ -38.37M
Net Income Common Stockholders	$ -41.52M	$ -41.96M	$ -36.98M	$ -24.28M	$ -40.73M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 49.81M	$ 54.63M	$ 258.85M	$ 281.18M	$ 277.15M
Total Assets	$ 312.67M	$ 355.60M	$ 308.19M	$ 350.62M	$ 370.15M
Total Debt	$ 29.16M	$ 30.61M	$ 8.00M	$ 9.34M	$ 10.66M
Net Debt	$ -20.66M	$ -24.01M	$ -250.85M	$ -271.84M	$ -266.48M
Total Liabilities	$ 143.93M	$ 155.10M	$ 74.38M	$ 90.70M	$ 96.10M
Stockholders Equity	$ 168.75M	$ 200.49M	$ 233.86M	$ 259.88M	$ 274.05M
Cash Flow	-
Free Cash Flow	$ -44.84M	$ 24.10M	$ -43.59M	$ -19.55M	$ 901.00K
Operating Cash Flow	$ -41.95M	$ 26.69M	$ -41.13M	$ -18.47M	$ 901.00K
Investing Cash Flow	$ 35.51M	$ -14.37M	$ 22.77M	$ 43.83M	$ 16.07M
Financing Cash Flow	$ 1.62M	$ 7.00K	$ 1.70M	$ 25.00K	$ 1.48M

Currency in USD

Nurix Therapeutics Earnings and Revenue History

Income Statement >

Nurix Therapeutics Debt to Assets

Balance Sheet >

Nurix Therapeutics Cash Flow

Cash Flow >

Nurix Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing